Inactive Instrument
Aimmune Therapeutics, Inc. Stock
Stocks
AIMT
US00900T1079
Biotechnology & Medical Research
| 1 day | -0.29% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/13/20 | Nestle Health Science SA (Private Equity)
| Buy | Company | 54,117,287 | 82.6848% | |
| 10/13/20 | Others | Director | 109,372 | 0.1671% | ||
| 10/10/20 | Tender | Chief Executive Officer | 879,672 | 1.3440% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.29% | +0.20% | - | - | 2.27B | ||
| +0.24% | -1.54% | +52.85% | +71.85% | 53.83B | ||
| -7.17% | -4.39% | +42.72% | +73.32% | 52.1B | ||
| +0.80% | -6.31% | +5.62% | +417.78% | 23.48B | ||
| -0.09% | -0.01% | -16.85% | -15.41% | 23.13B | ||
| -5.95% | -2.58% | +29.53% | -9.47% | 19.36B | ||
| -1.14% | +0.03% | +31.67% | -30.65% | 17.56B | ||
| -5.16% | -7.00% | +168.44% | +314.96% | 15.2B | ||
| -6.91% | -5.83% | +25.17% | +644.30% | 14.83B | ||
| +0.43% | -1.03% | +25.75% | +189.74% | 14.06B | ||
| Average | -2.52% | -2.62% | +40.54% | +184.05% | 25.95B | |
| Weighted average by Cap. | -2.78% | -2.36% | +39.55% | +143.13% |
Employees
-
















